After Nine Years of ALK Drugs, Lung Cancer Switches Gears—and a Second Mutation Saves the Day
A case report documents an ALK-rearranged lung cancer patient who acquired a druggable EGFR L858R mutation after nearly nine years ...
A case report documents an ALK-rearranged lung cancer patient who acquired a druggable EGFR L858R mutation after nearly nine years ...
A new review in Molecular Cancer argues that extrachromosomal DNA acts as a dynamic epigenetic reprogramming platform that reshapes chromatin, ...
A new Nature Genetics study combines spatial transcriptomics and lineage tracing to map how lung tumor subclones expand, reshape their ...
A new review proposes a Dynamic Precision Oncology framework that monitors pancreatic cancer's evolving resistance mechanisms through longitudinal genomic, liquid ...
A new Nature study integrates multiple classes of genomic mutations to define the distinct mutational processes that shape prostate cancer ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine